ORAL ADMINISTRATION OF PEPTIDE THERAPEUTICS, SUCH AS GLP-1

Patent Number: WO-2024110614-A1

Publication Year: 2024

Application Year: 2023

Priority Year: 2022

Jurisdictions: WO

Status: N/A

Inventors:

BÆKDAL TINE AGGERHOLM WELCH JOHANNA EMMA CARITA HAUGAARD SINE PFEIFFER HATORP VIBEKE HELENE ZACHO JEPPE

Applicants:

  1. Novo Nordisk (Denmark)
  2. [NORA names: Novo Nordisk; Private Research; Denmark; Europe, EU; Nordic; OECD]

Abstract

Disclosed herein are compositions comprising a GLP-1 peptide and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid for use as a medicament by oral administration.

Patent Family Records (1)

ORAL ADMINISTRATION OF PEPTIDE THERAPEUTICS, SUCH AS GLP-1

NOVO NORDISK AS, Novo Nordisk (Denmark) BÆKDAL TINE AGGERHOLM, WELCH JOHANNA EMMA CARITA, HAUGAARD SINE PFEIFFER, (...more)

2024, WO-2024110614-A1

Data Provider: Digital Science